Cesium carbonate → (S)-2,2-Difluoro-2-(1-hydroxy-3,3,5,5-tetramethylcyclohexyl)-1-(2-(5-((pyridazin-4-yloxy)methyl)isoxazol-3-yl)pyrrolidin-1-yl)ethanone

HRID 710068

反応式

HRID 710068 の反応式
[F:1][C:2]([F:28])([C:17]1([OH:27])[CH2:22][C:21]([CH3:24])([CH3:23])[CH2:20][C:19]([CH3:26])([CH3:25])[CH2:18]1)[C:3]([N:5]1[CH2:9][CH2:8][CH2:7][C@H:6]1[C:10]1[CH:14]=[C:13]([CH2:15][OH:16])[O:12][N:11]=1)=[O:4].Br.Br[C:31]1[CH:36]=[CH:35][N:34]=[N:33][CH:32]=1.C([O-])([O-])=O.[Cs+].[Cs+].C1(C2C3C(=CC=CC=3)C=CC=2)C2C(=CC=CC=2)C=CC=1P(C(C)(C)C)C(C)(C)C>CC([O-])=O.CC([O-])=O.[Pd+2].C1(C)C=CC=CC=1>[F:28][C:2]([F:1])([C:17]1([OH:27])[CH2:18][C:19]([CH3:26])([CH3:25])[CH2:20][C:21]([CH3:24])([CH3:23])[CH2:22]1)[C:3]([N:5]1[CH2:9][CH2:8][CH2:7][C@H:6]1[C:10]1[CH:14]=[C:13]([CH2:15][O:16][C:31]2[CH:36]=[CH:35][N:34]=[N:33][CH:32]=2)[O:12][N:11]=1)=[O:4]

参加物

7

反応物 4

HCID 10796Cesium carbonateHCID 2734941(1,1'-Binaphthalen)-2-yldi-tert-butylphosphineHCID 534079064-Bromopyridazine hydrobromideHCID 86706747(S)-2,2-Difluoro-2-(1-hydroxy-3,3,5,5-tetramethylcyclohexyl)-1-(2-(5-(hydroxymethyl)isoxazol-3-yl)pyrrolidin-1-yl)ethanone

生成物 1

HCID 86706781(S)-2,2-Difluoro-2-(1-hydroxy-3,3,5,5-tetramethylcyclohexyl)-1-(2-(5-((pyridazin-4-yloxy)methyl)isoxazol-3-yl)pyrrolidin-1-yl)ethanone収率 16.7%

試薬・触媒・溶媒 2

HCID 167845palladium(II) acetate触媒HCID 1140Toluene溶媒

反応条件

温度
100 °C

実験手順

A sealed tube was charged with a mixture prepared by adding toluene (2 ml) to Compound 18 (30 mg), 4-bromopyridazine hydrobromide (22 mg), Pd(OAc)2 (2 mg), Cs2CO3 (37 mg), and [1,1′-binaphthalen]-2-yldi-tert-butylphosphine (3 mg) and the mixture was stirred at 100° C. for 4 hours. After cooling the reaction mixture to room temperature, NH silica gel was added, followed by stirring for a while. After separating the silica gel by filtration, the silica gel was washed with chloroform and the solvent was distilled off; the resulting residue was purified by reverse-phase preparative HPLC to give the titled compound (6.0 mg, colorless oil.)

後処理

  1. additionA sealed tube was charged with a mixture
  2. customprepared
  3. temperatureAfter cooling the reaction mixture to room temperature
  4. additionNH silica gel was added
  5. stirringby stirring for a while
  6. customAfter separating the silica gel
  7. filtrationby filtration
  8. washthe silica gel was washed with chloroform
  9. distillationthe solvent was distilled off
  10. customthe resulting residue was purified by reverse-phase preparative HPLC

出典と根拠

ORDレコード
ord-a77022a34471403ea39f5d751aafaa39
出典データセット
uspto-grants-2015_11
特許番号
US09181229B2

関連ノート

読み込み中…